FDA-2024-0001-V201

Type IB variation for application FDA-2024-0001. Type IB variation: Labeling Change for Lorlatenilib — minor update

Variation Number
FDA-2024-0001-V201
Type
Type IB
Application
FDA-2024-0001
Change
CHG-2024-0201
Status
Failed
Fee
€1,431
Submitted
2023-08-11
Approved
—
Description

Type IB variation: Labeling Change for Lorlatenilib — minor update